Form D · Biotechnology
BioPhoundry, Inc.
Chapel Hill, NC · CIK 0002050545
Offering snapshot reported Jan 29, 2025 · SEC filing
- Reported sold
- $1.15M Offering amount: $1.24M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 10, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 29, 2025 | Initial | $1,145,098 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-536690
Source: Form D, filed Jan 29, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rani T. Brooks | Director, Executive |
| Sahan B.W. Liyanagedera | Director, Executive |
| Louis Marlow | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1521 E Franklin St C212
Chapel Hill, NC, 27514
Chapel Hill, NC, 27514